AIM and Singapore’s National University Hospital Sign Joint Research Agreement on Endoscopic AI

~ The research will be focused on testing the utility of Endoscopic AI in Singapore~

AI MEDICAL SERVICE INC., an emerging medical-tech company developing innovative endoscopic AI, reported today that on April 21, 2021, it signed a joint research agreement with National University Hospital of Singapore (hereinafter NUH), the only public hospital in the country.

AIM and NUH will utilize the agreement’s framework to explore topics such as demonstrations of the AI device and regulatory approval in Singapore.

AIM is working toward receiving regulatory approval in Japan for an endoscopic AI product that specializes in the identification of early-stage gastric cancer. AIM hopes to use the joint research with NUH to advance its regulatory approval and product awareness campaigns.

AIM and NUH will conduct a joint announcement after the joint research is completed, where further details will be discussed.

For inquiries on this matter, please contact the following:

Public Relations, AI Medical Service Inc. Email: pr@ai-ms.com